Intelligent Investor

Japara Healthcare Limited (ASX: JHC) - Announcements

DELISTED - Current share price for JHC : $1.400

ASX company news and announcements for Japara Healthcare Limited (JHC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Japara Healthcare Limited (JHC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Japara Healthcare Limited (JHC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Japara Healthcare Limited (JHC)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Change in substantial holding from BTT 31 Jul 2015 5:02PM $2.790 $1.400 $1.400 fallen by 49.82%
- Company Secretary Appointment 29 Jul 2015 4:14PM $2.700 $1.400 $1.400 fallen by 48.15%
- Ceasing to be a substantial holder from CGF 27 Jul 2015 4:55PM $2.700 $1.400 $1.400 fallen by 48.15%
- Becoming a substantial holder 14 Jul 2015 8:25AM $2.590 $1.400 $1.400 fallen by 45.95%
- Ceasing to be a substantial holder 2 Jul 2015 8:24AM $2.660 $1.400 $1.400 fallen by 47.37%
- Change in substantial holding from NAB 1 Jul 2015 5:33PM $2.660 $1.400 $1.400 fallen by 47.37%
- Annual Results Release Date 1 Jul 2015 11:57AM $2.570 $1.400 $1.400 fallen by 45.53%
- Change in substantial holding 22 Jun 2015 8:26AM $2.660 $1.400 $1.400 fallen by 47.37%
- Appointment of CFO 11 Jun 2015 10:53AM $2.660 $1.400 $1.400 fallen by 47.37%
- Change in substantial holding 9 Jun 2015 8:23AM $2.690 $1.400 $1.400 fallen by 47.96%
- Change in substantial holding from CGF 21 May 2015 4:12PM $2.850 $1.400 $1.400 fallen by 50.88%
- Change in substantial holding 15 May 2015 8:25AM $2.800 $1.400 $1.400 fallen by 50%
- Macquarie Australia Conference Presentation 7 May 2015 8:29AM $2.730 $1.400 $1.400 fallen by 48.72%
- Change in substantial holding 27 Apr 2015 8:27AM $2.680 $1.400 $1.400 fallen by 47.76%
- Appendix 4D and Interim Financial Report 26 Feb 2015 9:00AM $2.640 $1.400 $1.400 fallen by 46.97%
- Response to ASX Aware Query 5 Dec 2014 1:46PM $1.945 $1.400 $1.400 fallen by 28.02%
- 2014 ACAR Allocation Announcement 5 Dec 2014 10:13AM $1.940 $1.400 $1.400 fallen by 27.84%
- Japara Healthcare AGM CEO's Address 5 Nov 2014 1:50PM $2.600 $1.400 $1.400 fallen by 46.15%
- Japara Healthcare AGM Chairman's Address 5 Nov 2014 1:50PM $2.600 $1.400 $1.400 fallen by 46.15%
- Assumes operations of Whelan and on track for FY15 Guidance 5 Nov 2014 12:54PM $2.600 $1.400 $1.400 fallen by 46.15%
- Japara Healthcare Buys in Glen Waverley 27 Oct 2014 10:00AM $2.400 $1.400 $1.400 fallen by 41.67%
- Appendix 4E & 2014 Annual Financial Report 28 Aug 2014 9:47AM $2.180 $1.400 $1.400 fallen by 35.78%
- JHC signs contracts to acquire the Whelan Care Portfolio 25 Aug 2014 9:34AM $2.290 $1.400 $1.400 fallen by 38.86%
- Japara signs syndicated facility agreement 7 Aug 2014 5:20PM $2.310 $1.400 $1.400 fallen by 39.39%
- Announcement regarding Dementia Supplement 27 Jun 2014 9:58AM $2.300 $1.400 $1.400 fallen by 39.13%

351 - 375 of 378 results

Page 15 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.